beta

ALEC

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap:

Primary Exchange:

Website: /stocks/alec

Shares Outstanding:

Float:

Dividend: (%)

Beta:

Sector:

Industry:

Short Interest ():

Ethical Flags

Longest drawdown: 3 trading days

From: 2019-02-07 To: 2019-02-12

Lowest Point:

U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs

via: SeekingAlpha at 2019-02-09 11:13:47:000

In the second week after the SEC opened, we saw a number of launches and two billion-dollar biotechs, Alector (ALEC) and Gossamer Bio (GOSS), price their IPOs. Another biotech, Harpoon Therapeutics (HARP), along with three SPACs, also priced their IPOs. Alector, a Phase 1 biotech developing … read more...

U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs

via: SeekingAlpha at 2019-02-09 11:13:47:000

In the second week after the SEC opened, we saw a number of launches and two billion-dollar biotechs, Alector (ALEC) and Gossamer Bio (GOSS), price their IPOs. Another biotech, Harpoon Therapeutics (HARP), along with three SPACs, also priced their IPOs. Alector, a Phase 1 biotech developing … read more...

U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs

via: SeekingAlpha at 2019-02-09 11:13:47:000

In the second week after the SEC opened, we saw a number of launches and two billion-dollar biotechs, Alector (ALEC) and Gossamer Bio (GOSS), price their IPOs. Another biotech, Harpoon Therapeutics (HARP), along with three SPACs, also priced their IPOs. Alector, a Phase 1 biotech developing … read more...

U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs

via: SeekingAlpha at 2019-02-09 11:13:47:000

In the second week after the SEC opened, we saw a number of launches and two billion-dollar biotechs, Alector (ALEC) and Gossamer Bio (GOSS), price their IPOs. Another biotech, Harpoon Therapeutics (HARP), along with three SPACs, also priced their IPOs. Alector, a Phase 1 biotech developing … read more...

Alector prices IPO at $19

via: SeekingAlpha at 2019-02-07 02:40:03:000

Alector (NASDAQ: ALEC ) prices its IPO of 9.25M shares of common stock at $19.00/share, for expected gross proceeds of $176M. More news on: Alector, Inc., Healthcare stocks news, Read more … read more...

Alector prices IPO at $19

via: SeekingAlpha at 2019-02-07 02:40:03:000

Alector (NASDAQ: ALEC ) prices its IPO of 9.25M shares of common stock at $19.00/share, for expected gross proceeds of $176M. More news on: Alector, Inc., Healthcare stocks news, Read more … read more...

Alector Announces Pricing of Initial Public Offering

via: Business Wire at 2019-02-06 19:59:00:000

Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the pricing of its initial public offering of 9,250,000 shares of common stock to the public at $19.00 per sh… read more...

Alector Announces Pricing of Initial Public Offering

via: Business Wire at 2019-02-06 19:59:00:000

Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the pricing of its initial public offering of 9,250,000 shares of common stock to the public at $19.00 per sh… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX